ライフサイエンスコーパス: seroconvert

1 atients with PCR-confirmed infection did not seroconvert.

2 al challenges with SIV(mac251) and failed to seroconvert.

3 project who were exposed to HIV but did not seroconvert.

4 ate (CA2), even though these animals did not seroconvert.

5 on of HPV-16 DNA than were women who did not seroconvert.

6 monella organisms, after which they began to seroconvert.

7 tissue inflammatory response, and failed to seroconvert.

8 These ferrets did not shed the virus or seroconvert.

9 ers in sera than those whose infants did not seroconvert.

10 e immunity, but not all infected individuals seroconvert.

11 nd three of 41 placebo recipients (7%, 2-20) seroconverted.

12 cutive pregnancies, 15.6% (115/739) of women seroconverted.

13 in serum and IC were generally low, and 65% seroconverted.

14 buted 166 723 person-years of follow-up; 519 seroconverted.

15 r H+ pigs (66%) than non-A+ or H+ pigs (25%) seroconverted.

16 Overall, 64% of patients seroconverted.

17 oronasally and i.v. inoculated chickens had seroconverted.

18 l exposure group shed the virus in feces and seroconverted.

19 of 15 initially negative children, 5 (33.3%) seroconverted.

20 e from Europe, Australia, and Canada who had seroconverted.

21 ronegative for measles; of these, 44 (93.6%) seroconverted.

22 t exhibited mild clinical symptoms, but they seroconverted.

23 buted 166,723 person-years of follow-up; 519 seroconverted.

24 er, some women with persistent HPV DNA never seroconverted.

25 osures and remained asymptomatic, and no one seroconverted.

26 patients with HBV DNA levels >104 genomes/mL seroconverted.

27 ter 2 injections, all subjects in all groups seroconverted.

28 ds, and 50 to 60% of 3-, 4-, and 5-year-olds seroconverted.

29 ll horses at various time points; two horses seroconverted.

30 s and Swiss Webster mice inoculated with CA9 seroconverted.

31 whereas no participants in the placebo group seroconverted.

32 5 (20%) of 25 initially seronegative persons seroconverted.

33 and 67.1% of women with incident infections seroconverted.

34 lthough the virus replicated and the animals seroconverted.

35 All (53/53) type 2 seronegative children seroconverted.

36 patients (87.1%) sampled at day 14 or later seroconverted.

37 immunization and for 52 weeks for those who seroconverted.

38 For chimera 3, none of 9 subjects seroconverted.

39 Of those seronegative at baseline, 3.6% seroconverted.

40 235 (12%) individuals seroconverted.

41 and CD86 on B cells was high in patients who seroconverted.

42 en if either they or their male partners HIV seroconverted.

43 d more than one follow-up test and 238 (17%) seroconverted.

44 inical efficacy equivalent to the proportion seroconverting.

45 One transfusion recipient seroconverted (0.08% [1/1259]), but this patient did not

46 tients who did not receive transfusions also seroconverted (0.18% [1/556]).

47 Of 253 HIV-negative participants, 2 seroconverted (0.29/100 person-years at risk [pyar]); of

48 20 of 193 (10%) infants in the latter group seroconverted 1 week after mOPV2 challenge, resulting in

49 For chimera 4, 7 subjects seroconverted (1 received 10 PFU, 3 received 100 PFU, an

50 For chimera 2, 3 subjects seroconverted (1 received 100 PFU, and 2 received 1000 P

51 Thirty-six (15%) seroconverted (10%-12%/year).

52 Most ANDV-infected deer mice had seroconverted 14 days after inoculation, but none of the

53 dition, 80% (8/10; phase II) of infected RMs seroconverted 14 to 21 days postchallenge.

54 After first dose, 25.7% of patients seroconverted (26.6% AZ, 22.8% Pfizer).

55 -years in the control group 158 participants seroconverted (31.78 per 100 person-years; 26.83-36.74).

56 One full dose of intramuscular IPV seroconverted 33%, 41%, and 47% of infants against serot

57 less of OPV formulation, were less likely to seroconvert (47%; 95% confidence interval, 39%-54%) than

58 patients with Kaposi's sarcoma (52 percent) seroconverted 6 to 75 months before the clinical appeara

59 1, 2, and 3 on average, whereas 2 full doses seroconverted 79%, 80%, and 90%, respectively.

60 3-JJ recipients were 1.4-fold more likely to seroconvert (80% vs. 57%, weighted incidence-rate-ratio:

61 -JJ recipients were 1.41-fold more likely to seroconvert (88% vs. 59%, wIRR = (1.04) 1.41(1.93) , p =

62 rted than among those whose partners did not seroconvert (90,254 copies per milliliter vs. 38,029 cop

63 t year were 5.1 times as likely as others to seroconvert (95% CI 1.9-13.7).

64 had sex with men were 8.8 times as likely to seroconvert (95% CI 3.7-20.5) as heterosexual men.

65 histolytica infections, as 15.3% of controls seroconverted after 12 months of follow-up.

66 es at 0, 4, and 12-15-months, and almost all seroconverted after 2 doses given 8-11 months apart.

67 s who were HAV seronegative at baseline, 97% seroconverted after 2 vaccine doses, and 47% had low ant

68 cytomegalovirus (CMV); 6 (5 female, 1 male) seroconverted after a median of 7.5 months.

69 higher percentage of healthy subjects (93%) seroconverted after a single dose of the hepatitis A vac

70 noculated with tetravalent YF/DEN1-4 vaccine seroconverted after a single dose.

71 Mice that had seroconverted after exposure to P. carinii-infected SCID

72 bsequent dried blood spot tests, of whom 503 seroconverted after follow-up of 22 891 person-years.

73 ho were type-2 seronegative, 42 (100%) of 42 seroconverted after GlaxoSmithKline intramuscular IPV, a

74 The patient seroconverted after immune reconstitution during receipt

75 ) of 97 infants who were type-3 seronegative seroconverted after intramuscular IPV, and 21 (36%) of 4

76 rt, we identified one individual (LSC63) who seroconverted after over 2 years of repeated unprotected

77 of the children seronegative at age 9 months seroconverted after receiving two doses of measles vacci

78 However, 18 of 19 children seroconverted after revaccination.

79 Similarly, mothers whose infants' IgA seroconverted after RV1 had significantly lower pre-dose

80 nza-like symptoms and lung lesions, and they seroconverted after virus inoculation.

81 All participants seroconverted against all 4 serotypes after receiving 3

82 5,5,5,5) or a low-dose (3,3,3,3) formulation seroconverted against all four DEN virus serotypes.

83 r 6 months, and at 50 degrees C for 2 weeks, seroconverted against both RABV-G and EBOV-GP.

84 of 117, or 99%) of these young patients had seroconverted against Epstein-Barr virus, as compared wi

85 The cat seroconverted against SARS-CoV-2, further evidencing a p

86 h higher diarrhea scores were more likely to seroconvert and developed higher intestinal IgA and IgG

87 do not shed virus following infection but do seroconvert and mount an antiviral neutralizing antibody

88 ing 30% of the transplant recipients did not seroconvert and were asymptomatic.

89 who were HIV-negative, 536 were observed to seroconvert and were followed up for up to 13 years.

90 -FIV activity during acute infection did not seroconvert and yielded no evidence of FIV infection at

91 revalence was 75% (89 of 118) in infants who seroconverted and 80% (97 of 122) in infants who did not

92 The percentages of participants who seroconverted and achieved seroprotection were similar b

93 o experienced sapovirus GI.1 gastroenteritis seroconverted and developed genotype-specific IgG.

94 All vaccinated animals were seroconverted and developed neutralizing antibody respon

95 ss I loci was performed for 850 patients who seroconverted and had known dates of HIV-1 infection.

96 ct control pigs shed the virus in feces; two seroconverted and one became viremic.

97 Comparisons were made between children who seroconverted and progressed to type 1 diabetes (progres

98 ted; of the 15 whose serostatus changed, all seroconverted and were significantly younger than those

99 riments did not show clinical signs, did not seroconvert, and did not have detectable M. agassizii by

100 Uninoculated cage mates failed to seroconvert, and viral RNA was not detected in their tis

101 percent of the HuNoV-HS66-inoculated calves seroconverted, and 100% coproconverted with immunoglobul

102 men had acute HIV infection at enrollment, 4 seroconverted, and 2 were identified as recently infecte

103 Of 148 healthy child vaccinees, 113 (76%) seroconverted, and 24% had no detectable VZV FAMA antibo

104 All of the experimentally infected tortoises seroconverted, and levels of antibody were statistically

105 cattle in both treatment and contact groups seroconverted, and virus was detected in their respirato

106 in blood and indicated that most individuals seroconvert at around 10 DPSO.

107 These effects counterbalance, and women who seroconverted at 24-30 weeks of gestation carried the hi

108 The inoculated turkeys seroconverted at 4 to 8 wpi.

109 ens inoculated with the 10(-2) dilution also seroconverted at 8 wpi.

110 [5-21] at 10 years among those patients who seroconverted at ages < 15, 15-34, 35-54, and > or = 55)

111 Both animals seroconverted at least 6 months after the interruption o

112 y-infused animal until week 12; both animals seroconverted at week 14.

113 le genes of the gtrA,B, gtr(type) cluster in seroconverting bacteriophages.

114 f the AIDS-KS patients who were examined IgG-seroconverted before KS development, and antibody levels

115 An additional 22% seroconverted before or after transplant, and were asymp

116 ow percentage (0.81%) of these were found to seroconvert between these two surveys.

117 15.6% (115/739) of women seroconverted between 2 consecutive pregnancies.

118 group and 157 of 1 184 in the placebo group seroconverted between months 13 and 25, giving a vaccine

119 e-control study comparing 58 respondents who seroconverted between visits with 1134 controls who rema

120 eived EBV+ grafts; 8 others with EBV+ grafts seroconverted but did not become symptomatic.

121 ificantly lower than in men who subsequently seroconverted but had no evidence of early infection.

122 ccines) developed subclinical infections and seroconverted but were only partially protected against

123 d PCR amplification, whereas several rabbits seroconverted but were PCR and culture negative.

124 All infected mice seroconverted by 14 days postinfection.

125 l cases, including asymptomatic individuals, seroconverted by 2 weeks after PCR confirmation.

126 H. hepaticus-infected mice seroconverted by 2 weeks and maintained ELISA reactivity

127 All ERBs seroconverted by 21 days post-infection.

128 and groups 3 and 4 became virus positive and seroconverted by 3 to 5 weeks postinoculation.

129 BTV-inoculated mice were seroconverted by 7 and 5 dpi, and reached peak levels by

130 Of these, 676 (98.8%) seroconverted by age 16 months.

131 On the basis of an aoHGE lysate ELISA, mice seroconverted by day 10 after inoculation.

132 tibody reactivity, and only six case mothers seroconverted by either assay.

133 s: one, four, four, and one person of eleven seroconverted by haemagglutination inhibition, microneut

134 detected within tetramer-specific T cells in seroconverted children.

135 We found that 13 of 22 D(+)R(-) LTRs (59.1%) seroconverted (CMV IgG Ab(+)).

136 After second dose, 148 (42.8%) of AZ seroconverted compared with 130 (52.6%) of Pfizer (P = 0

137 he booster dose, 98% of compensated patients seroconverted compared with 65.7% with decompensated dis

138 h-child-mortality settings had lower odds of seroconverting compared with infants in low-child-mortal

139 The group of 536 who seroconverted constituted the study population.

140 Twenty of these specimens were from recently seroconverted drug-naive persons, and 30 were from patie

141 first pandemic wave, 12.2% of the population seroconverted due to infection and the seroprevalence af

142 and the proportion of those susceptible that seroconverted due to infection, from a single sample of

143 icate that 30% of children and 33% of adults seroconvert during interferon-alpha treatment and follow

144 is necessary to identify and treat women who seroconvert during pregnancy).

145 al 124 mothers, 81 had at least 1 child KSHV seroconvert during the 2 years analyzed, while the remai

146 we attempted to classify TDR among women who seroconverted during 2008-2010 and who were identified f

147 Four of 17 initially seronegative partners seroconverted during 23 person-years of observation.

148 ined asymptomatic, and none of these animals seroconverted during an extended quarantine period.

149 y, 3371 were HIV positive on entry, and 2737 seroconverted during follow-up (1962 had a seroconversio

150 413 initially HIV-uninfected participants, 8 seroconverted during follow-up.

151 ants included those who had prevalent HIV or seroconverted during follow-up; all were antiretroviral-

152 on the transmission bottleneck in women who seroconverted during the CAPRISA 004 microbicide trial.

153 est with a cycle threshold (C(T) ) of <35 or seroconverted during the follow-up period, yielding an a

154 Eight children seroconverted during the outbreak without revaccination

155 The women who seroconverted during the trial reported a significant in

156 Children who seroconverted early in life (median age <2 years) and de

157 0) of the 28 controls with follow-up samples seroconverted (exact p value = 0.0008).

158 IV strains from transmitting males and their seroconverting female partners found that the males' gen

159 ent HPV DNA was associated with a failure to seroconvert following incident HPV infection; however, s

160 ree of 109 (30.3%) infants in the WASH group seroconverted following rotavirus vaccination, compared

161 Patients were more likely to seroconvert for a cross-reactive antigen if they serocon

162 All HIV-infected participants seroconverted for all HPV types, but seroconversion rang

163 63/111 (57%) of seronegative SOT recipients seroconverted for at least one MMRV virus.

164 valent or serotype G1-G4 tetravalent vaccine seroconverted for at least one of the six antibodies (85

165 erson-years of follow-up [PYFU], 16 patients seroconverted for HDV, with an overall incidence rate of

166 ected every 2-7 days from 15 individuals who seroconverted for HIV-1 infection in 1994-2000.

167 A total of 118 of 134 women (88.1%) seroconverted for HPV-16 after the first dose; 4 weeks a

168 dent HPV infections, 59.5%, 54.1%, and 68.8% seroconverted for HPV-16, -18, or -6, respectively, with

169 He subsequently seroconverted for syphilis.

170 convert for a cross-reactive antigen if they seroconverted for the specific vaccine antigen.

171 tive sex partners of HTLV-I and -II carriers seroconverted, for an incidence rate (IR) of 0.6 transmi

172 hepatitis B e antigen-positive patients who seroconverted from hepatitis B e antigen to hepatitis B

173 15 875 individuals seroconverting from 1979 to 2008 fulfilled the inclusion

174 children, 73% older children and 72% adults seroconverted (>/=4 fold titer rise) after the 1(st) OCV

175 up without seasonal vaccination, 32% of HCWs seroconverted (>=4-fold increase in HI titers) during th

176 Interestingly, patients who seroconverted had significantly lower serum levels of G-

177 When excluding these seroconverted HCWs, HI titers gradually declined from 12

178 patients close to the time when the partner seroconverted (hereafter, "SC samples"); for 31 pairs, s

179 was well tolerated in all macaques, and all seroconverted (high neutralizing antibody [PRNT80 titers

180 of mice with soluble protein (sTat), and in seroconverting humans, and propose that Tat-induced supp

181 h sera obtained from four pregnant women who seroconverted (IgG and IgM antibodies) during pregnancy

182 Dogs have been demonstrated to seroconvert in response to diverse IAVs, and naturally o

183 ll product were significantly more likely to seroconvert in response to the influenza vaccine (P = .0

184 After MMR3, 82% (14/17) and 91% (10/11) seroconverted in 7-10 days and 2-3 months, respectively.

185 homologous to the outbreak strain, but most seroconverted in response to other genetically distinct

186 nfection in disease progression in women who seroconverted in the CAPRISA 004 tenofovir microbicide t

187 of the 415 initially HIV-1-negative partners seroconverted (incidence, 11.8 per 100 person-years).

188 0 person-years of follow-up, 29 participants seroconverted (incidence: 10.0/100 person-years).

189 By day 14, 39% had seroconverted, increasing to 87% by day 28 and 100% by 3

190 ity by needle inoculation, but injected mice seroconverted, indicating an ability to activate the ada

191 +)IFN-gamma(+) T cells in the PBMC of 90% of seroconverted individuals following primary infection by

192 -negative OFOQ results occurred in 80 of 287 seroconverting individuals.

193 Similarly, among those who seroconverted, infants in high-child-mortality settings

194 milar sequences were also determined from 18 seroconverting injection drug users in Baltimore.

195 ion of HIV-1 env sequences was studied in 15 seroconverting injection drug users selected for differe

196 93.4% of naive HCWs seroconverted, irrespective of age and gender.

197 eripheral blood mononuclear cells of the EBV-seroconverted kidney recipient 20 months after lymphoma

198 y day 57, 52 (92%) of vaccine recipients had seroconverted (microneutralisation titre >/=1:10), with

199 titres, the percentage of participants that seroconverted, microneutralisation titres, and the numbe

200 d and 80% (97 of 122) in infants who did not seroconvert (odds ratio, 0.79; 95% confidence interval,

201 In contrast, among infants who seroconverted, OPV concomitantly administered with both

202 The number of infants who seroconverted or had a four-fold rise in titres was also

203 rotavirus vaccine had 0.63 times the odds of seroconverting (OR = 0.63, 95% CI 0.47-0.84, p = 0.002)

204 who had >/=1 additional HCV Ab test, 23 (6%) seroconverted over 1408 person-years, for an annualized

205 respiratory disease than those that did not seroconvert (P < 0.001), and dogs with preexisting antib

206 cell losses (P < or = 0.013), and failure to seroconvert (P < or = 0.005) were correlated statistical

207 ng transplant recipients were more likely to seroconvert (P = .002) and vaccine recipients were less

208 ) and vaccine recipients were less likely to seroconvert (P = .024).

209 evels significantly higher than in the never-seroconverted (P = 0.02) and the pre-seroconverted (P =

210 e never-seroconverted (P = 0.02) and the pre-seroconverted (P = 0.03) children, but then declined to

211 iable models, early set-point viral loads in seroconverting partners were a complex function of (i) t

212 all pairs near the time of transmission, and seroconverting partners were followed for a median of 84

213 Of 64 seroconverted patients followed for at least 30 months o

214 Eighty-two of the 142 seroconverted patients have stopped producing antibody t

215 Among seroconverted patients, after 30-36 mo of treatment, sev

216 high proportion of SRA positivity among EIA-seroconverting patients (8/11 [73%]) suggests that patie

217 ng the gp120 proteins of isolates from early seroconverting patients.

218 f infection (FOI, the proportion of children seroconverting per year) under assumptions of either age

219 The majority (75%) of the seroconverted population had no detectable levels of cir

220 Thirteen infected dogs (group A), which seroconverted rapidly (maximum titers within 50 to 90 da

221 R(+) CD8(+) T cells was greater in those who seroconverted, relative to the frequency in those who re

222 in addition to bOPV, 80% and 100% of infants seroconverted, respectively, and the vaccination induced

223 101 (3%), 41 (33%), and 25 (1%) of patients seroconverted, respectively.

224 Twelve seroconverted rhesus macaques were reinoculated with hom

225 By day 14, 39% had seroconverted, rising to 87% by day 28 and 100% by 3 mon

226 first, a person who initiates PrEP must not seroconvert; second, there should be no more than one pe

227 receptive anal intercourse without a condom seroconverted significantly more often than those report

228 gh sex between men, aged 30-39 years, having seroconverted since 2006, enrolled within 6 months of se

229 ogs with mild or no clinical signs (group B) seroconverted slowly (peak titers after 90 days), and on

230 Few of the seroconverting subjects reported hepatitis-like illness.

231 rtner who injected drugs were less likely to seroconvert than other women (0.32 [0.11-0.92]).

232 l (to <104 genomes/mL) appear more likely to seroconvert than patients who do not achieve this level

233 en younger than 40 years were more likely to seroconvert than those 40 years or older (2.8 [1.05-7.6]

234 among HIV-1-positive subjects whose partners seroconverted than among those whose partners did not se

235 For chimera 1, 1 of 9 seroconverted (the seroconverter received 100 PFU).

236 possibility that a population subset may not seroconvert to develop SARS-CoV-2 antibodies post-COVID-

237 Moreover, treatment responders did not seroconvert to islet cell antibodies.

238 ernatants from the same cell line, failed to seroconvert to VCA and did not develop disease.

239 e, 47 (62%) of 76 participants given vaccine seroconverted to all four serotypes and 73 (96%) partici

240 h1 cytokines in patients who cleared HBV and seroconverted to anti- hepatitis B e, unlike the 23 nonr

241 Five seroconverted to anti-HBs (responders).

242 he Transfusion-Transmitted Viruses Study who seroconverted to anti-HCV after receiving infected blood

243 All HEV-inoculated pigs seroconverted to anti-HEV immunoglobulin G.

244 he virus in feces; two pigs were viremic and seroconverted to anti-HEV.

245 However, fewer than one-third seroconverted to any prototype G1-G4 human rotavirus.

246 Five of ten animals seroconverted to C. trachomatis.

247 t by day 62 postvaccination, 100% of animals seroconverted to DENV-1, -2, -3, and -4.

248 icipants, 39% (420/1077) and 53% (1595/2997) seroconverted to DENV-3 and DENV-4, respectively.

249 L/129 IL-10(-/-) mice were colonized and had seroconverted to H. saguini antigen with a significant T

250 ependent regression analyses: 48 of 195 IDUs seroconverted to HCV, for an incidence rate of 25.1/100

251 mean follow-up time, 39 months), 69 (33.2%) seroconverted to HCV.

252 (elevated liver enzyme levels in serum) and seroconverted to HEV, those receiving an inoculum incuba

253 in 10 persons with chronic HCV infection who seroconverted to HIV and, over the next 3 years, had slo

254 Overall, 277 persons seroconverted to HIV during 8,826.45 person-years of fol

255 case-control study of 116 case subjects who seroconverted to HIV during follow-up and 342 control su

256 to HIV-1 were compared with 184 men who had seroconverted to HIV positive and had lower risk.

257 tions (23.6/100 person-years), and 265 women seroconverted to HIV-1 (7.7/100 person-years).

258 A total of 85 men seroconverted to HIV-1 over the period of observation, g

259 45 women seroconverted to HIV.

260 P. vivax or P. falciparum, >60% of subjects seroconverted to homologous CSP and MSP-1.

261 after the third QHPV dose, 67% of vaccinees seroconverted to HPV31, an HPV16-related genotype not in

262 A total of 131 participants seroconverted to HSV-2 (79 of 1041 assigned to tenofovir

263 children vaccinated at 15 months of age, 98% seroconverted to measles, compared with 95% of those vac

264 with GAS pharyngitis and invasive infections seroconverted to most of the 16 recombinant proteins, wh

265 unvaccinated participants, of whom 100 (31%) seroconverted to NAI alone.

266 In the first outbreak, only three of nine seroconverted to NV, which was likely due to late collec

267 f the 106 eligible pairs tested, 21 patients seroconverted to one or more antigens.

268 Most animals seroconverted to only a subset of these fimbrial antigen

269 Group 2 and 5 pigs all seroconverted to PCV1 antibody.

270 tvaccination (DPV), the majority of pigs had seroconverted to PCV2 capsid antibody.

271 Inoculated rabbits seroconverted to positivity for antibodies against HTLV-

272 canis, and 25 to Bartonella vinsonii, and 22 seroconverted to Rickettsia rickettsii antigens.

273 Five of the six volunteers seroconverted to S. enterica serovar Typhimurium antigen

274 Three of six (three of five who seroconverted to Salmonella) had immune responses in the

275 In the azithromycin group, 175 (50%) seroconverted to serotype-3 poliovirus compared with 192

276 al signs and symptoms of GAS pharyngitis and seroconverted to several GAS extracellular proteins.

277 ive infections and pharyngitis caused by GAS seroconverted to Shp, indicating that Shp was produced i

278 and patients with streptococcal pharyngitis seroconverted to Sse, indicating that Sse was produced i

279 Each monkey immunized with TV-1 and TV-3 seroconverted to the four DEN components by day 28 with

280 , and 16% of initially seronegative subjects seroconverted to the H3N2, B, and H1N1 antigens, respect

281 iitis) caused by six distinct M types of GAS seroconverted to the streptococcal cysteine protease.

282 dual patients demonstrated that the majority seroconverted to these proteins, confirming results with

283 all four serotypes and 73 (96%) participants seroconverted to three or more dengue viruses.

284 ants (100%, 98.0-100; p<0.0001 vs bOPV-only) seroconverted to type 2.

285 apsid antigen (VCA) of EBV; all animals that seroconverted to VCA developed malignant lymphoma within

286 For assay development: 104 persons seroconverting to HIV-1 comprising 38 plasma donors, 18

287 The proportions of children seroconverting to type 2 poliovirus in the IPV-bOPV-bOPV

288 h Procleix HCV reactive/seronegative results seroconverted upon follow-up and were confirmed as Procl

289 Women who seroconverted were 5.7 times (95% confidence interval =

290 iduals enrolled in the iPrEx trial who later seroconverted were matched with 480 samples from enrolle

291 ir resistance remains a concern in women who seroconvert while using the gel despite the lack of plas

292 Dogs that were seronegative on entry but seroconverted while in the kennel were 4 times more like

293 Only 9% of subjects who received LAIV seroconverted, while 33% of patients developed at least

294 shed virus nasally or rectally, but all pigs seroconverted with antibodies to HRV.

295 rrhea and fecal and nasal virus shedding and seroconverted with serum and intestinal HRV antibodies.

296 88.7% seroconverted, with significantly lower seroconversion r

297 unodeficiency virus type 1 (HIV-1) typically seroconvert within weeks of primary infection.

298 CR positive within 3 weeks postinfection and seroconverted without exhibiting clinical disease; howev

299 In contrast, almost all of those who seroconverted without illness (97%) experienced primary

300 Among seroconverting Zambian (n = 240) and Rwandan (n = 64) pa